Chemistry Reference
In-Depth Information
REFERENCES
1. Vasconcelos, T., Sarmento, B., and Costa, P. (2007) Solid dispersions as strategy to improve
oral bioavailability of poor water soluble drugs.
Drug Discov. Today
, 12(23-24):1068-1074.
2. Chiou, W.L. and Riegelman, S. (1969) Preparation and dissolution characteristics of several
fast-release solid dispersions of griseofulvin.
1510.
3. Hancock, B.C. and Parks, M. (2000) What is the true solubility advantage for amorphous
pharmaceuticals?
Pharm. Res.
, 17(4):397-404.
4. Six, K., Verreck, G., Peeters, J., Brewster, M., and Van den Mooter, G. (2004) Increased
physical stability and improved dissolution properties of itraconazole, a class II drug, by solid
dispersions that combine fast- and slow-dissolving polymers.
J. Pharm. Sci.
, 93(1):124-131.
5. Kawabata, Y., Wada, K., Nakatani, M., Yamada, S., and Pnoue, S. (2011) Formulation design
for poorly water-soluble drugs based on biopharmaceutics classification system: basic
approaches and practical applications.
Int. J. Pharm.
, 420(1):1-10.
6. Pokharkar, V.B., Mandpe, L.P., Padamwar, M.N., Ambike, A.A., Mahadik, K.R., and
Paradkar, A. (2006) Development, characterization and stabilization of amorphous form of
a low
T
g
drug.
Powder Technol.
, 167(1):20-25.
7. Van den Mooter, G., Weuts, I., De Ridder, T., and Blaton, N. (2006) Evaluation of Inutec SP1
as a new carrier in the formulation of solid dispersions of poorly soluble drugs.
Int. J. Pharm.
,
316(1-2):1-6.
8. Chauhan, B., Shimpi, S., and Paradkar, A. (2005) Preparation and evaluation of glibencla-
mide-polyglycolized glycerides solid dispersions with silicon dioxide by spray drying
technique.
Eur. J. Pharm. Sci.
, 26(2):219-230.
9. Vasanthavada, M., Tong, W.-Q., Joshi, Y., and Kislalioglu, S. (2004) Phase behavior of
amorphous molecular dispersions I: determination of the degree and mechanism of solid
solubility.
Pharm. Res.
, 21(9):1598-1606.
10. Johari, G.P., Kim, S., and Shanker, R.M. (2005) Dielectric studies of molecular motions in
amorphous solid and ultraviscous acetaminophen.
J. Pharm. Sci.
, 94(10):2207-2233.
11. Wang, X., Michoel, A., and Van der Mooter, G. (2005) Solid state characteristics of ternary
solid dispersions composed of PVP VA64, Myrj 52 and itraconazole.
J. Pharm. Sci.
, 58(12):1505
-
Int. J. Pharm.
,
303(1-2):54-61.
12. Breitenbach, J. (2002) Melt extrusion: from process to drug delivery technology.
Eur. J.
Pharm. Biopharm.
, 54(2):107-117.
13. DiNunzio, J.C., Zhang, F., Martin, C., and McGinity, J.W. (2012) Melt extrusion. In:
Williams, R.O., III, Watts, R.O, and Miller, D.A. (Eds.),
Formulating Poorly Water Soluble
Drugs
, AAPS Press/Springer, New York, pp. 311-362.
14. Miller D.A. and Gil, M. (2012) Spray drying technology. In: Williams, R.O., III, Watts, A.B.,
and Miller, D.A. (Eds.),
Formulating Poorly Water Soluble Drugs
, AAPS Press/Springer,
New York, pp. 363-442.
15. Passerini N., Albertini, B., Perissutti, B., and Rodriguez, L. (2006) Evaluation of melt
granulation and ultrasonic spray congealing as techniques to enhance the dissolution of
praziquantel.
Int. J. Pharm.
, 318(1-2):92-102.
16. Vilhelmsen, T., Eliasen, H., and Schaefer, T. (2005) Effect of a melt agglomeration process on
agglomerates containing solid dispersions.
Int. J. Pharm.
, 303(1-2):132-142.
